Repligen Corp

NASDAQ:RGENUnited States

Repligen Corporation is a life sciences company, which develops and commercializes bioprocessing technologies and systems that rises flexibility in the process of manufacturing biological drugs. The Company's bioprocessing business consist of four franchises, filtration; chromatography; process analytics; and proteins. The Filtration products are used in process development and process scale production. The Chromatography franchise includes products used in downstream purification, development, and manufacturing of biological drugs. The Process Analytics products allow end-users to make in-line absorbance measurements allowing for the determination of protein concentration in filtration, chromatography formulation and fill-finish applications. The Proteins franchise is represented by its Protein A affinity ligands, which are a critical component of Protein A chromatography resins used in downstream purification of virtually all monoclonal antibody (mAb) based drugs on the market.

Contact Information

Headquarters

BUILDING 1, SUITE 100, 41 SEYON STREETWALTHAM, MA, United States 02453

Phone

781-449-9560

Fax

302-655-5049

Executives

Independent Chairperson of the Board

Karen Dawes

President, Chief Commercial Officer

Olivier Loeillot

Chief Executive Officer, Director

Tony Hunt

Chief Financial Officer

Jason Garland

Chief Operating Officer

James Bylund